PortfoliosLab logoPortfoliosLab logo
QNRX vs. HMC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

QNRX vs. HMC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quoin Pharmaceuticals Ltd DRC (QNRX) and Honda Motor Co., Ltd. (HMC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, QNRX achieves a -69.44% return, which is significantly lower than HMC's -11.84% return.


QNRX

1D
-5.16%
1M
-7.55%
YTD
-69.44%
6M
-67.93%
1Y
-49.31%
3Y*
-73.86%
5Y*
-85.89%
10Y*

HMC

1D
-1.03%
1M
-1.81%
YTD
-11.84%
6M
-14.05%
1Y
-8.94%
3Y*
-1.98%
5Y*
-0.78%
10Y*
3.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

QNRX vs. HMC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
QNRX
Quoin Pharmaceuticals Ltd DRC
-69.44%-36.64%-86.73%-71.21%-93.76%-78.94%-2.70%-78.86%-70.00%126.54%
HMC
Honda Motor Co., Ltd.
-11.84%8.04%-5.14%39.86%-16.69%3.61%2.88%10.34%-20.81%20.02%

Correlation

The correlation between QNRX and HMC is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Jul 29, 2016

0.12

The correlation between QNRX and HMC shifts across timeframes, from -0.05 (1 year) to 0.13 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

QNRX:

$12.48M

HMC:

$34.77B

EPS

QNRX:

-$13.39

HMC:

-¥321.49

PB Ratio

QNRX:

1.42

HMC:

0.47

Total Revenue (TTM)

QNRX:

$0.00

HMC:

¥22.00T

Gross Profit (TTM)

QNRX:

-$24.93K

HMC:

¥3.63T

EBITDA (TTM)

QNRX:

-$17.28M

HMC:

¥1.01T

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

QNRX vs. HMC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QNRX
QNRX Risk / Return Rank: 3434
Overall Rank
QNRX Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
QNRX Sortino Ratio Rank: 4848
Sortino Ratio Rank
QNRX Omega Ratio Rank: 4848
Omega Ratio Rank
QNRX Calmar Ratio Rank: 2020
Calmar Ratio Rank
QNRX Martin Ratio Rank: 2222
Martin Ratio Rank

HMC
HMC Risk / Return Rank: 2929
Overall Rank
HMC Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
HMC Sortino Ratio Rank: 2626
Sortino Ratio Rank
HMC Omega Ratio Rank: 2626
Omega Ratio Rank
HMC Calmar Ratio Rank: 3232
Calmar Ratio Rank
HMC Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QNRX vs. HMC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quoin Pharmaceuticals Ltd DRC (QNRX) and Honda Motor Co., Ltd. (HMC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


QNRXHMCDifference
Sharpe ratioReturn per unit of total volatility

+0.03

Sortino ratioReturn per unit of downside risk

+0.96

Omega ratioGain probability vs. loss probability

1.09

0.97

+0.12

Calmar ratioReturn relative to maximum drawdown

-0.61

-0.29

-0.32

Martin ratioReturn relative to average drawdown

-0.98

-0.56

-0.42

QNRX vs. HMC - Sharpe Ratio Comparison

The current QNRX Sharpe Ratio is -0.26, which is comparable to the HMC Sharpe Ratio of -0.29. The chart below compares the historical Sharpe Ratios of QNRX and HMC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

QNRX vs. HMC - Drawdown Comparison

The maximum QNRX drawdown since its inception was -100.00%, which is greater than HMC's maximum drawdown of -90.46%. Use the drawdown chart below to compare losses from any high point for QNRX and HMC.


Loading charts...

Drawdown Indicators


QNRXHMCDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-90.46%

-9.54%

Max Drawdown (1Y)

Largest decline over 1 year

-81.17%

-31.18%

-49.99%

Max Drawdown (3Y)

Largest decline over 3 years

-98.68%

-35.41%

-63.27%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

-35.41%

-64.59%

Max Drawdown (10Y)

Largest decline over 10 years

-43.12%

Current Drawdown

Current decline from peak

-100.00%

-25.89%

-74.11%

Average Drawdown

Average peak-to-trough decline

-81.53%

-36.09%

-45.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.56%

15.99%

+34.57%

Volatility

QNRX vs. HMC - Volatility Comparison

Quoin Pharmaceuticals Ltd DRC (QNRX) has a higher volatility of 23.57% compared to Honda Motor Co., Ltd. (HMC) at 10.08%. This indicates that QNRX's price experiences larger fluctuations and is considered to be riskier than HMC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


QNRXHMCDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.57%

10.08%

+13.49%

Volatility (6M)

Calculated over the trailing 6-month period

60.92%

21.53%

+39.39%

Volatility (1Y)

Calculated over the trailing 1-year period

190.41%

30.52%

+159.89%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

213.65%

26.99%

+186.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

172.31%

25.48%

+146.83%

Dividends

QNRX vs. HMC - Dividend Comparison

QNRX has not paid dividends to shareholders, while HMC's dividend yield for the trailing twelve months is around 2.62%.


PositionTTM20252024202320222021202020192018201720162015
HMC
Honda Motor Co., Ltd.
2.62%4.67%3.19%3.29%4.00%3.08%2.72%2.90%2.27%2.45%2.87%2.86%
QNRX
Quoin Pharmaceuticals Ltd DRC
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

QNRX vs. HMC - Financials Comparison

This section allows you to compare key financial metrics between Quoin Pharmaceuticals Ltd DRC and Honda Motor Co., Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00T2.00T3.00T4.00T5.00T6.00T202220232024202520260
5.93T
(QNRX) Total Revenue
(HMC) Total Revenue
Please note, different currencies. QNRX values in USD, HMC values in JPY

Frequently Asked Questions


QNRX and HMC have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

QNRX has higher volatility (23.57%) compared to HMC (10.08%). In terms of maximum drawdown, QNRX dropped -100.00% vs HMC's -90.46%.

QNRX currently has the higher Sharpe Ratio (-0.26 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for QNRX and HMC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer